Matches in SemOpenAlex for { <https://semopenalex.org/work/W2395434206> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2395434206 endingPage "20S" @default.
- W2395434206 startingPage "14S" @default.
- W2395434206 abstract "The role of aminoglycosides in the treatment of infective endocarditis is well established. The combination of a beta-lactam with an aminoglycoside shortens the treatment of endocarditis due to penicillin-sensitive streptococci (MIC < or = 0.1 micrograms/mL) when compared to beta-lactams alone. Patients at higher risk (e.g. with prosthetic valves, clinical duration of symptoms > 3 months) should be treated with penicillin for 4 weeks in combination with an aminoglycoside for 2 weeks. Once-daily dosing (ODD) of aminoglycosides can be recommended in penicillin-sensitive streptococcal endocarditis. The treatment of endocarditis due to streptococci relatively and/or highly resistant to penicillin requires combined treatment with penicillin plus an aminoglycoside for a longer duration. At present ODD of aminoglycosides cannot be recommended. Enterococcal endocarditis requires combined treatment for 4 to 6 weeks. Based upon experimental data, ODD of aminoglycosides appears to be markedly inferior to q 8 h dosing. Enterococcal isolates should be screened for high-level resistance to streptomycin and gentamicin. Gentamicin is the preferred agent if susceptibility testing is not performed. Aminoglycosides are administered during the initial 3 to 5 days of treatment for staphylococcal endocarditis on native valves in order to shorten the duration of bacteremia. For staphylococcal prosthetic valve endocarditis, aminoglycosides are administered for the initial 2 weeks of treatment. However, there are no reliable clinical data for methicillin-susceptible isolates to support this recommendation. In prosthetic valve endocarditis due to coagulase-negative staphylococci combination with an aminoglycoside appears to suppress the emergence of rifampin-resistant variants during treatment. There are no data on ODD of aminoglycosides in staphylococcal endocarditis. Right-sided staphylococcal endocarditis due to methicillin-susceptible staphylococci is adequately treated with a two-week course of a beta-lactam plus an aminoglycoside. This short regimen can be recommended for low risk patients, e.g. those without significant heart failure and vegetations < 2 cm3 and with an aminoglycoside-susceptible isolate." @default.
- W2395434206 created "2016-06-24" @default.
- W2395434206 creator A5058428387 @default.
- W2395434206 date "1996-01-01" @default.
- W2395434206 modified "2023-10-18" @default.
- W2395434206 title "[Aminoglycosides in the treatment of infectious endocarditis]." @default.
- W2395434206 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8677414" @default.
- W2395434206 hasPublicationYear "1996" @default.
- W2395434206 type Work @default.
- W2395434206 sameAs 2395434206 @default.
- W2395434206 citedByCount "0" @default.
- W2395434206 crossrefType "journal-article" @default.
- W2395434206 hasAuthorship W2395434206A5058428387 @default.
- W2395434206 hasConcept C126322002 @default.
- W2395434206 hasConcept C141071460 @default.
- W2395434206 hasConcept C174802600 @default.
- W2395434206 hasConcept C2775832221 @default.
- W2395434206 hasConcept C2775843808 @default.
- W2395434206 hasConcept C2775872228 @default.
- W2395434206 hasConcept C2777288759 @default.
- W2395434206 hasConcept C2777787772 @default.
- W2395434206 hasConcept C2779443120 @default.
- W2395434206 hasConcept C2780176578 @default.
- W2395434206 hasConcept C501593827 @default.
- W2395434206 hasConcept C71924100 @default.
- W2395434206 hasConcept C86803240 @default.
- W2395434206 hasConcept C89423630 @default.
- W2395434206 hasConceptScore W2395434206C126322002 @default.
- W2395434206 hasConceptScore W2395434206C141071460 @default.
- W2395434206 hasConceptScore W2395434206C174802600 @default.
- W2395434206 hasConceptScore W2395434206C2775832221 @default.
- W2395434206 hasConceptScore W2395434206C2775843808 @default.
- W2395434206 hasConceptScore W2395434206C2775872228 @default.
- W2395434206 hasConceptScore W2395434206C2777288759 @default.
- W2395434206 hasConceptScore W2395434206C2777787772 @default.
- W2395434206 hasConceptScore W2395434206C2779443120 @default.
- W2395434206 hasConceptScore W2395434206C2780176578 @default.
- W2395434206 hasConceptScore W2395434206C501593827 @default.
- W2395434206 hasConceptScore W2395434206C71924100 @default.
- W2395434206 hasConceptScore W2395434206C86803240 @default.
- W2395434206 hasConceptScore W2395434206C89423630 @default.
- W2395434206 hasLocation W23954342061 @default.
- W2395434206 hasOpenAccess W2395434206 @default.
- W2395434206 hasPrimaryLocation W23954342061 @default.
- W2395434206 hasRelatedWork W1991461017 @default.
- W2395434206 hasRelatedWork W1994432625 @default.
- W2395434206 hasRelatedWork W2002019392 @default.
- W2395434206 hasRelatedWork W2127874167 @default.
- W2395434206 hasRelatedWork W2315980083 @default.
- W2395434206 hasRelatedWork W2318809673 @default.
- W2395434206 hasRelatedWork W2395434206 @default.
- W2395434206 hasRelatedWork W2413481107 @default.
- W2395434206 hasRelatedWork W2431908121 @default.
- W2395434206 hasRelatedWork W2473297343 @default.
- W2395434206 hasVolume "76" @default.
- W2395434206 isParatext "false" @default.
- W2395434206 isRetracted "false" @default.
- W2395434206 magId "2395434206" @default.
- W2395434206 workType "article" @default.